<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathogenesis of spontaneous bacterial peritonitis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathogenesis of spontaneous bacterial peritonitis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathogenesis of spontaneous bacterial peritonitis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruce A Runyon, MD, FAASLD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keith D Lindor, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intra-abdominal surgically treatable source [<a href="#rid1">1</a>]. The presence of infection is documented by a positive ascitic fluid bacterial culture and an elevated ascitic fluid absolute polymorphonuclear leukocyte (PMN) count (≥250 cells/mm<sup>3</sup>). </p><p>The absolute PMN count is calculated by multiplying the total white blood cell count (or total "nucleated cell" count) by the percentage of PMNs in the differential. The cell count and differential are performed manually without formal quality control. The accuracy of these tests is totally dependent upon the skill and interest of the medical technologist. (See  <a class="medical medical_review" href="/z/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a>.)</p><p>This topic will review our understanding of the pathogenesis of SBP. The clinical manifestations, diagnosis, and treatment of SBP are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1247.html" rel="external">"Spontaneous bacterial peritonitis in adults: Clinical manifestations"</a> and  <a class="medical medical_review" href="/z/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis"</a>.) </p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>When the phrase spontaneous bacterial peritonitis was coined in 1964, the descriptor "spontaneous" was used because the pathogenesis of the infection was not apparent [<a href="#rid1">1</a>]. Over the past decades, this void of information has been at least partially filled [<a href="#rid2">2</a>]  (<a class="graphic graphic_figure graphicRef52311" href="/z/d/graphic/52311.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H3"><span class="h2">Microbiology and bacterial entry into ascitic fluid</span><span class="headingEndMark"> — </span>One of the early steps in the development of SBP is a disturbance in gut flora with overgrowth and extraintestinal dissemination of a specific organism, most commonly <em>Escherichia coli</em>  (<a class="graphic graphic_table graphicRef80188" href="/z/d/graphic/80188.html" rel="external">table 1</a>) [<a href="#rid3">3,4</a>]. Cirrhosis predisposes to the development of bacterial overgrowth, possibly because of altered small intestinal motility [<a href="#rid5">5</a>], and the presence of hypochlorhydria due to use of proton pump inhibitors [<a href="#rid6">6</a>]. In addition, patients with cirrhosis may have increased intestinal permeability [<a href="#rid7">7</a>].</p><p>However, the role of bacterial overgrowth in the pathogenesis of SBP remains unsettled. In one study, small bowel motility and bacterial overgrowth were compared in 20 patients with cirrhosis and a history of SBP and 20 patients with cirrhosis without a history of SBP [<a href="#rid8">8</a>]. The prevalence of bacterial overgrowth was higher in the patients with a history of SBP (70 versus 20 percent); these patients also exhibited more severe small intestinal motility disturbances. In contrast, in another study, the presence of bacterial overgrowth was not associated with the development of SBP [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/4776.html" rel="external">"Small intestinal bacterial overgrowth: Clinical manifestations and diagnosis"</a>.)</p><p>Whether or not they are present in increased numbers, bacteria within the gut lumen can traverse the intestinal wall, and colonize mesenteric lymph nodes. This phenomenon is called translocation and has been documented to occur in animal models of cirrhosis and SBP [<a href="#rid3">3,4</a>]. Bacterascites can occur if the lymphatics carrying the contaminated lymph rupture because of the high flow and high pressure associated with portal hypertension [<a href="#rid10">10</a>]. Alternatively, the organism can move from the mesenteric lymphatics to the systemic circulation and then percolate through the liver and weep across Glisson's capsule to enter the ascitic fluid.</p><p>Several studies have demonstrated that bacterial translocation is also increased in patients with advanced cirrhosis [<a href="#rid11">11,12</a>]. In an illustrative study, mesenteric lymph nodes were obtained from 101 patients with cirrhosis and from 35 non-cirrhotic controls [<a href="#rid12">12</a>]. Enteric organisms were grown from culture in only 8.6 percent of controls compared to 3.4, 8.1, and 30.8 percent of patients with Child class A, B, and C cirrhosis, respectively. Selective intestinal decontamination reduced the rate of positive cultures to that of non-cirrhotic patients.</p><p>Other studies have shown molecular evidence of bacterial translocation and suggested that it occurs prior to the development of clinical SBP [<a href="#rid13">13,14</a>]. Patients with cirrhosis and ascites can have bacterial DNA in their serum and ascitic fluid even when viable organisms cannot be cultured [<a href="#rid15">15</a>]. Low levels of translocation of intact bacteria or pieces of bacteria may lead to activation of tumor necrosis factor (TNF), which may explain the higher levels of TNF that have been observed in patients who ultimately develop SBP compared with controls [<a href="#rid16">16</a>]. The presence of bacterial DNA in serum and ascitic fluid is a risk factor for death in patients with cirrhosis [<a href="#rid17">17</a>]. Proton pump inhibitors increased bacterial translocation in an animal model of SBP and also increase the risk of SBP in humans [<a href="#rid18">18,19</a>]. Proton pump inhibitors have also been shown in humans to decrease phagocyte oxidative burst; this could further handicap defenses against resident bacteria [<a href="#rid20">20</a>].</p><p>A novel mechanism that appears to enhance translocation is reduction in thickness of colonic mucus followed by bacteria-to-epithelial cell contact [<a href="#rid21">21</a>]. Bacteria isolated from patients with SBP have been shown to disrupt cell junctions [<a href="#rid21">21</a>]. Blocking this disruption could provide a nonantibiotic method of preventing SBP.  </p><p>Bacteria that eventually cause SBP can also originate in sites other than the gut via bacteremic seeding. These include urinary tract infections [<a href="#rid22">22</a>], pneumococcal sepsis [<a href="#rid10">10</a>], cellulitis, pharyngitis, and dental infections. These infections are labeled "spontaneous" because they are not amenable to surgical therapy. Surgically treatable infections, eg, perforated duodenal ulcer, that lead to ascitic fluid infection are called secondary bacterial peritonitis. (See  <a class="medical medical_review" href="/z/d/html/1249.html" rel="external">"Spontaneous bacterial peritonitis in adults: Diagnosis"</a>.) The pathogenesis of this form of peritonitis is quite different than that of SBP; millions of bacteria flood into the peritoneum through the rent in the gut wall.</p><p class="headingAnchor" id="H4"><span class="h2">Host defenses</span><span class="headingEndMark"> — </span>Once the organism enters ascitic fluid, a battle ensues between the virulence of the bacteria and the host's resistance to infection. Microbes that cause SBP are usually serum-resistant, ie, they cannot be killed by serum alone but also require functional phagocytes [<a href="#rid23">23</a>]. Foreign matter is first "opsonized" with complement and/or globulin so that it is more identifiable by and digestible to phagocytes [<a href="#rid23">23</a>].</p><p>The resident macrophages represent the first line of defense of the peritoneal cavity [<a href="#rid24">24,25</a>]. If these phagocytes fail to eradicate the colonizing microbes, complement is activated and cytokines are released. PMNs enter the peritoneum to seek and destroy the invading organisms. If, however, complement levels are inadequate or the PMNs are dysfunctional, then colonization may not be contained and a potentially fatal infection may ensue.</p><p>Cirrhosis is actually one of the most common forms of acquired immune deficiency, creating an environment that facilitates the persistence of peritoneal infection [<a href="#rid26">26</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Serum complement deficiency is quite common in patients with liver disease that is advanced enough to produce ascites [<a href="#rid27">27</a>]. Furthermore, ascitic fluid is frequently a fivefold or even 10-fold dilution of serum in patients with cirrhosis; thus, ascitic fluid complement concentrations may drop to levels similar to those of the serum of patients with congenital complement deficiency [<a href="#rid27">27,28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The function of both motile (eg, PMNs) and stationary phagocytes (eg, Kupffer cells) is reduced in patients with advanced liver disease [<a href="#rid29">29-31</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h1">RISK FACTORS FOR SBP</span><span class="headingEndMark"> — </span>The vast majority of patients with SBP have advanced cirrhosis [<a href="#rid1">1</a>]. Other risk factors for SBP include [<a href="#rid27">27,32-35</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Ascitic fluid total protein concentration less than 1 g/dL (&lt;10 g/L).</p><p class="bulletIndent1"><span class="glyph">●</span>Prior episode of SBP.</p><p class="bulletIndent1"><span class="glyph">●</span>Serum total bilirubin concentration above 2.5 mg/dL.</p><p class="bulletIndent1"><span class="glyph">●</span>Variceal hemorrhage.</p><p class="bulletIndent1"><span class="glyph">●</span>Possibly malnutrition [<a href="#rid11">11</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Use of proton pump inhibitors [<a href="#rid18">18,36-38</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Use of nonselective beta blockers [<a href="#rid38">38</a>].</p><p></p><p>In a database study including over 350,000 patients with cirrhosis, use of proton pump inhibitors was associated with higher risk of SBP compared with no proton pump inhibitor use (odds ratio [OR] 2.31, 95% CI 2.21-2.42) [<a href="#rid38">38</a>]. Similarly, use of nonselective beta blockers was associated with higher risk of SBP (OR 1.26, 95% CI 1.21-1.31). These findings support evaluating the indications for and risk of using such medications in patients with cirrhosis, and these issues are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/121754.html" rel="external">"Overview of medication adjustments for adult patients with cirrhosis"</a> and  <a class="medical medical_review" href="/z/d/html/1263.html" rel="external">"Cirrhosis in adults: Overview of complications, general management, and prognosis"</a>.)</p><p>The combination of certain clinical and laboratory features is also associated with an increased risk of SBP [<a href="#rid39">39,40</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>An ascitic fluid total protein &lt;1.5 g/dL (&lt;15 g/L) with</p><p class="bulletIndent1"><span class="glyph">●</span>Child-Pugh score ≥9 points with serum bilirubin ≥3 mg/dL or with</p><p class="bulletIndent1"><span class="glyph">●</span>Plasma creatinine ≥1.2 mg/dL, blood urea nitrogen ≥25 mg/dL or plasma sodium ≤130 mEq/L</p><p></p><p>Patients who meet the above combination criteria should be considered candidates for antibiotic prophylaxis. (See  <a class="medical medical_review" href="/z/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis"</a>.)</p><p>Malignancy-related ascites and cardiac ascites can become infected, but this is rare enough to be the subject of case reports [<a href="#rid41">41,42</a>]. When peritoneal carcinomatosis is associated with SBP, the organism is unusual and quite virulent, eg, Salmonella [<a href="#rid43">43</a>]. Nephrotic ascites can also become spontaneously infected [<a href="#rid44">44</a>].</p><p>Genetic variation in <em>TNFA</em> (<em>TNFA</em> c.-238A allele) has been associated with a decreased risk of serious bacterial infections in patients awaiting liver transplantation (hazard ratio 0.42, 95% CI 0.20-0.90) [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H117406752"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background </strong>– Spontaneous bacterial peritonitis (SBP) is defined as an ascitic fluid infection without an evident intra-abdominal surgically treatable source. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1">When the phrase spontaneous bacterial peritonitis was coined in 1964, the descriptor "spontaneous" was used because the pathogenesis of the infection was not apparent. Over the past decades, this void of information has been at least partially filled  (<a class="graphic graphic_figure graphicRef52311" href="/z/d/graphic/52311.html" rel="external">figure 1</a>). (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology </strong>– One of the early steps in the development of SBP is a disturbance in gut flora with overgrowth and extraintestinal dissemination of a specific organism, most commonly <em>Escherichia coli</em>  (<a class="graphic graphic_table graphicRef80188" href="/z/d/graphic/80188.html" rel="external">table 1</a>). Cirrhosis predisposes to the development of bacterial overgrowth, possibly because of altered small intestinal motility, and the presence of hypochlorhydria due to use of proton pump inhibitors. In addition, patients with cirrhosis may have increased intestinal permeability. (See <a class="local">'Microbiology and bacterial entry into ascitic fluid'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Host defenses </strong>– Cirrhosis represents a form of acquired immune deficiency, creating an environment that facilitates the persistence of peritoneal infection. Mechanisms resulting in altered host defenses in patients with cirrhosis include complement deficiency and reduced phagocytosis. (See <a class="local">'Host defenses'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors </strong>– The vast majority of patients with SBP have advanced cirrhosis, but additional risk factors have been identified (see <a class="local">'Risk factors for SBP'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ascitic fluid total protein concentration less than 1 g/dL (&lt;10 g/L)</p><p class="bulletIndent2"><span class="glyph">•</span>Prior episode of SBP</p><p class="bulletIndent2"><span class="glyph">•</span>Serum total bilirubin concentration above 2.5 mg/dL</p><p class="bulletIndent2"><span class="glyph">•</span>Variceal hemorrhage</p><p class="bulletIndent2"><span class="glyph">•</span>Possibly malnutrition</p><p class="bulletIndent2"><span class="glyph">•</span>Use of proton pump inhibitors</p><p class="bulletIndent2"><span class="glyph">•</span>Use of nonselective beta blockers</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management </strong>– Treatment and prophylaxis of SBP are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">CONN HO. SPONTANEOUS PERITONITIS AND BACTEREMIA IN LAENNEC'S CIRRHOSIS CAUSED BY ENTERIC ORGANISMS. A RELATIVELY COMMON BUT RARELY RECOGNIZED SYNDROME. Ann Intern Med 1964; 60:568.</a></li><li><a class="nounderline abstract_t">Sheer TA, Runyon BA. Spontaneous bacterial peritonitis. Dig Dis 2005; 23:39.</a></li><li><a class="nounderline abstract_t">Guarner C, Runyon BA, Young S, et al. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26:1372.</a></li><li><a class="nounderline abstract_t">Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21:792.</a></li><li><a class="nounderline abstract_t">Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997; 42:738.</a></li><li><a class="nounderline abstract_t">Sánchez E, Soriano G, Mirelis B, et al. Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol 2015; 27:570.</a></li><li><a class="nounderline abstract_t">Scarpellini E, Valenza V, Gabrielli M, et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105:323.</a></li><li><a class="nounderline abstract_t">Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28:1187.</a></li><li><a class="nounderline abstract_t">Bauer TM, Steinbrückner B, Brinkmann FE, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol 2001; 96:2962.</a></li><li><a class="nounderline abstract_t">Guarner C, Runyon BA. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management. Gastroenterologist 1995; 3:311.</a></li><li><a class="nounderline abstract_t">Casafont F, Sánchez E, Martín L, et al. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Hepatology 1997; 25:1334.</a></li><li><a class="nounderline abstract_t">Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34:32.</a></li><li><a class="nounderline abstract_t">Runyon BA. Early events in spontaneous bacterial peritonitis. Gut 2004; 53:782.</a></li><li><a class="nounderline abstract_t">Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41:422.</a></li><li><a class="nounderline abstract_t">Such J, Francés R, Muñoz C, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002; 36:135.</a></li><li><a class="nounderline abstract_t">Such J, Hillebrand DJ, Guarner C, et al. Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001; 46:2360.</a></li><li><a class="nounderline abstract_t">Zapater P, Francés R, González-Navajas JM, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. Hepatology 2008; 48:1924.</a></li><li><a class="nounderline abstract_t">Bajaj JS, Zadvornova Y, Heuman DM, et al. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 2009; 104:1130.</a></li><li><a class="nounderline abstract_t">Sanchez E, Soriano G, Mirelis B. Effect of long-term inhibition of acid gastric secretion on gastric pH and on bacterial translocation in cirrhotic rats (abstract). Hepatology 2007; 46 Suppl:604A.</a></li><li><a class="nounderline abstract_t">Garcia-Martinez I, Francés R, Zapater P, et al. Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis. J Gastroenterol Hepatol 2015; 30:147.</a></li><li><a class="nounderline abstract_t">Haderer M, Neubert P, Rinner E, et al. Novel pathomechanism for spontaneous bacterial peritonitis: disruption of cell junctions by cellular and bacterial proteases. Gut 2022; 71:580.</a></li><li><a class="nounderline abstract_t">Ho H, Zuckerman MJ, Ho TK, et al. Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis. Am J Gastroenterol 1996; 91:735.</a></li><li><a class="nounderline abstract_t">Runyon BA, Morrissey RL, Hoefs JC, Wyle FA. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 1985; 5:634.</a></li><li><a class="nounderline abstract_t">Dunn DL, Barke RA, Knight NB, et al. Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 1985; 49:257.</a></li><li><a class="nounderline abstract_t">Ruiz-Alcaraz AJ, Martínez-Banaclocha H, Marín-Sánchez P, et al. Isolation of functional mature peritoneal macrophages from healthy humans. Immunol Cell Biol 2020; 98:114.</a></li><li><a class="nounderline abstract_t">Runyon BA. Bacterial infections in patients with cirrhosis. J Hepatol 1993; 18:271.</a></li><li><a class="nounderline abstract_t">Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology 1986; 91:1343.</a></li><li><a class="nounderline abstract_t">Runyon BA. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis. Hepatology 1988; 8:632.</a></li><li><a class="nounderline abstract_t">Laffi G, Carloni V, Baldi E, et al. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. Gastroenterology 1993; 105:170.</a></li><li><a class="nounderline abstract_t">Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4:53.</a></li><li><a class="nounderline abstract_t">Tritto G, Frances R, Shah N. Plasma from stable patients with cirrhosis transmits severe neutrophil phagocytic dysfunction which is independent of the presence of bacterial DNA and associated with increased expression of TLR-4. Hepatology 2009; 50:311A.</a></li><li><a class="nounderline abstract_t">Titó L, Rimola A, Ginès P, et al. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8:27.</a></li><li><a class="nounderline abstract_t">Llach J, Rimola A, Navasa M, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16:724.</a></li><li><a class="nounderline abstract_t">Andreu M, Sola R, Sitges-Serra A, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993; 104:1133.</a></li><li><a class="nounderline abstract_t">Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5:463.</a></li><li><a class="nounderline abstract_t">Goel GA, Deshpande A, Lopez R, et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol 2012; 10:422.</a></li><li><a class="nounderline abstract_t">Min YW, Lim KS, Min BH, et al. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study. Aliment Pharmacol Ther 2014; 40:695.</a></li><li><a class="nounderline abstract_t">Boustany A, Rahhal R, Onwuzo S, et al. Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study. Ann Gastroenterol 2023; 36:327.</a></li><li><a class="nounderline abstract_t">Fernández J, Navasa M, Planas R, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007; 133:818.</a></li><li><a class="nounderline abstract_t">European Association for the Study of the Liver. Electronic address: <span class="__cf_email__" data-cfemail="325753415e5d54545b5157725753415e5d54545b51571c5747">[email protected]</span>, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018; 69:406.</a></li><li><a class="nounderline abstract_t">Kurtz RC, Bronzo RL. Does spontaneous bacterial peritonitis occur in malignant ascites? Am J Gastroenterol 1982; 77:146.</a></li><li><a class="nounderline abstract_t">Runyon BA. Spontaneous bacterial peritonitis associated with cardiac ascites. Am J Gastroenterol 1984; 79:796.</a></li><li><a class="nounderline abstract_t">Woolf GM, Runyon BA. Spontaneous Salmonella infection of high-protein noncirrhotic ascites. J Clin Gastroenterol 1990; 12:430.</a></li><li><a class="nounderline abstract_t">Ackerman Z. Ascites in Nephrotic syndrome. Incidence, patients' characteristics, and complications. J Clin Gastroenterol 1996; 22:31.</a></li><li><a class="nounderline abstract_t">Senkerikova R, de Mare-Bredemeijer E, Frankova S, et al. Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation. J Hepatol 2014; 60:773.</a></li></ol></div><div id="topicVersionRevision">Topic 1246 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14138877" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : SPONTANEOUS PERITONITIS AND BACTEREMIA IN LAENNEC'S CIRRHOSIS CAUSED BY ENTERIC ORGANISMS. A RELATIVELY COMMON BUT RARELY RECOGNIZED SYNDROME.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15920324" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9210626" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7890896" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9125642" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25822866" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19844200" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9794900" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11693333" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8775093" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9185748" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11211904" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Bacterial translocation of enteric organisms in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15138202" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Early events in spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15723320" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bacterial translocation (BT) in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12085357" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11713936" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19003911" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19337238" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effect of long-term inhibition of acid gastric secretion on gastric pH and on bacterial translocation in cirrhotic rats (abstract)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25039465" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33707230" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Novel pathomechanism for spontaneous bacterial peritonitis: disruption of cell junctions by cellular and bacterial proteases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8677940" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4018735" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3894229" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31709677" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Isolation of functional mature peritoneal macrophages from healthy humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8228117" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Bacterial infections in patients with cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3770358" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3371881" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8390378" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6693068" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Plasma from stable patients with cirrhosis transmits severe neutrophil phagocytic dysfunction which is independent of the presence of bacterial DNA and associated with increased expression of TLR-4</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3257456" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1505916" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8462803" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3873389" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22155557" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25078671" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37144010" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17854593" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29653741" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7081173" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Does spontaneous bacterial peritonitis occur in malignant ascites?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6486115" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Spontaneous bacterial peritonitis associated with cardiac ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2204653" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Spontaneous Salmonella infection of high-protein noncirrhotic ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8776092" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Ascites in Nephrotic syndrome. Incidence, patients' characteristics, and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24361409" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
